depletion in vivo of asgm-1+ cells before the onset of il 2 administration eliminated the successful therapy of 3-day pulmonary metastases from nonimmunogenic sarcomas , with concurrent elimination of lak cell activity in the lungs .
C0153676
pulmonary metastases
C0024109
lungs